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Abstract
Two hundred, one-day-old broiler chicks were divided into groups 1, 2 and 3 containing 60, 70 and
70 chicks, respectively. The groups were divided into subgroups of 10 chicks that were vaccinated
according to the following scheme: group 1 unvaccinated control, group 2 vaccinated
subcutaneously at 1 day old with inactivated oil adjuvant vaccine (IOAV) in combination with live
B1 vaccine. Group 3 was vaccinated in the same mode as group 2 with IOAV and live Ulster 2C
vaccine. All birds were challenged when they were 28 days old. Mortality rate, body weight gain
and feed conversion ratio (FCR) were monitored before and after challenge. All the chickens in
group 1 died, indicating that there was no disease resistance of this unvaccinated control group of
chickens. Conversely, the monitored disease resistance of chickens in groups 2 and 3 was 68.57%
± 18.64 and 88.57% ± 9.00, respectively (P < 0.05). The morbidity of chickens in groups 2 and 3
was 37.89% ± 14.36 and 14.76% ± 12.40, respectively (P < 0.05). The body weight gain, feed intake
and FCR of group 3 were significantly better than those of group 2 (P < 0.05) during 1–42 days old.
The simultaneous vaccination with B1 or Ulster 2C and IOAV of 1-day-old chicks gave some
protection of 28-day-old broilers without a booster vaccination.
Introduction
Newcastle disease (ND), caused by ND virus (NDV)
which is an Avulavirus [1] is one of the most important
disease encountered in the poultry industry. The first
reported ND outbreak occured in 1926 in Java (Indone-
sia) [2]. ND infection takes place through virus inhalation
or ingestion and its spread from one bird to another
depends on the availability of the virus in its virulent
infectious form [3] and its short incubation period of 5–6
days. The disease normally affects the respiratory, gas-
trointestinal and nervous systems. Clinical signs associ-
ated with ND often begin with listlessness, increased
respiration rate and weakness followed later by prostation
and death. Morbidity and mortality rates of infected birds
vary from 1–100% [4] with the former reaching upto
100% and with the later escalating to 50% in adult birds
and 90% in young chickens.
Today there are commercial live and inactivated oil adju-
vant vaccines (IOAV) which are very effective as immuni-
zation antigens [5]. The live ones are produced from
lentogenic and mesogenic virus strains [6]. Live len-
togenic strains namely F, Hitchner B1 and La Sota and
mesogenic virus strains namely Mukteswar and Komarov
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are commercially available. The ND Ulster virus strain has
been reported to induce a very mild or inapparent disease
in susceptible chickens [7-9] after vaccination. Its efficacy
of a drinking water-administered and its potential as an
aerosol vaccines have been reported by Beard [10] and
Gough and Allan [11]. The Ulster strain is known to trig-
ger immunity in the vaccinated chickens with less efficacy
than strain Hitchner B1 when given as aerosol vaccine.
However, Ulster strain vaccine causes less side effects than
B1 [12-15].
Various kinds of live vaccination techniques namely, oral
administration through drinking water, course spray, eye-
drop, intranasal instillation, subcutaneous and muscle
injection have been described [16]. Undesirable vaccina-
tion reactions following administration of live ND vac-
cines are economically important in the broiler industry
especially if they result in adverse disease effects (e.g. col-
ibacillosis), growth retardation and sometimes even mor-
tality. On the other hand IOAV based vaccine does not
provoke undesirable reactions. However, both types of
vaccines and their administration by injection are rela-
tively expensive. In addition, IOAV vaccinated one-day-
old broiler chicks which also possess natural maternal
antibodies show pronounced immunity between 3 and 4
weeks of age [17].
A combination of live and inactivated vaccination pro-
gramme is recommended for endemic areas because vac-
cine combination is known to promote far better
immunological protection than administration of only
single live vaccine. There are several kinds of vaccination
programmes practised in Thailand for broiler chickens.
Some of these cause undesirable immunization reactions,
which disrupt the level of protective immunity of chicks.
As an attempt to circumvent this problem we describe
herein a comparative study on vaccination of broiler
chicks which were immunized with inactivated vaccine in
combination with live B1 or Ulster 2C vaccine strains. B1
and Ulster 2C are vaccinal isolates of NDV, which repli-
cate in the Harderian gland and induce IgA in the tears
[18]. Ulster 2C is known to stimulate immunity in the
intestinal loop rather than in the respiratory tract and




Unvaccinated 1-day-old ROSS-308 broiler chicks,
obtained from a commercial hatchery were used for the
pathogenicity and serology studies. The chicks were main-
tained in isolation units in the temperature-controlled
rooms. They were fed ad lib on commercial poultry feed
(Betagro, Bangkok, Thailand). Chickens were identified
individually by numbered leg tags. Guidelines and legisla-
tive regulations on the use of animals for scientific pur-
poses of Chulalongkorn University, Bangkok, Thailand
were followed.
Strains of Newcastle disease virus
The Ulster 2C (Poulvac-NDW, Fort Dodge Saúde Animal
Ltda, Campinas SP, Brazil) and B1 virus strains (Fort
Dodge Animal Health, Fort Dodge, Iowa, U.S.A.) used in
the experiment were reconstituted from freeze-dried vials.
According to the manufacturers' recommendations, each
vaccine is in 1000 dose vials, one dose being at least 105.7
and 106.5 50% embryo infective dose (EID50)/bird, respec-
tively. IOAV (Kimber strain, Chick N-K, Fort Dodge Ani-
mal Health, Fort Dodge, Iowa, U.S.A.) was administered
subcutaneously at the nape of each chick in 0.1 ml (109
TCID50/bird).
Challenge study
At 4 wk after vaccination (28 days old) all of the birds
were moved to the isolation unit, and each bird was chal-
lenged with the viscerotropic velogenic NDV (vvNDV)
strain (ICPI = 1.8), at a dose of 106 EID50/bird. Protection
was determined for a period of 14 days after challenge.
The parameters used to evaluate protection from NDV
were birds showing clinical signs and dead birds. This was
recorded as morbidity and mortality, respectively.
Immunization and virus challenge
The live vaccines were administered by coarse spray in a
Select laboratory cabinet. The following immunization
scheme was applied. Group 1: unvaccinated control group
(n = 60 chickens), the broilers received no vaccine. Group
2 (n = 70), the broilers were vaccinated at 1-day-old chicks
with strain B1 live vaccine given by course spray in com-
bination with IOAV vaccine administered subcutaneously
at the nape of each. Group 3 (n = 70), the broilers were
vaccinated at 1-day-old with Ulster 2C by couse spray in
combination with IOAV vaccine also administered as in
group 2. Chickens in all the 3 groups were further kept in
groups of 10 chickens. At 28 days old, all chickens were
weighed, amount of feed intake measured for calculation
of feed conversion ratio (FCR) and they were all chal-
lenged with NDV. Following vaccination and challenge,
all chickens were observed for any adverse clinical symp-
toms (morbidity) and mortality for 2 weeks. At 42 days
old, all chickens were weighed and the amount of feed
intake was measured from which FCR was determined.
Statistical analysis
FCR were analyzed and compared between groups using
an independent Student's t-test with SPSS 9.0 software.
Morbility and mortality were calculated by using Chi-
square values. Differences between groups were consid-
ered significant at p < 0.05.Acta Veterinaria Scandinavica 2006, 48:2 http://www.actavetscand.com/content/48/1/2
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Results
The protective efficacy of different NDV strains
All chickens in group 1 died during 28–42 days old after
challenge. The clinical signs in affected birds included
gasping, paralysis and torticollis. The autopsy lesions con-
firmed Newcastle disease virus infection depicted by hem-
orrhage in proventriculus, small intestine, caecal tonsil,
rectum, heart muscle, coronary fat and pneumonitis. The
mortality rate of chickens in the vaccinated groups 2
(31.43 ± 18.64) and 3 (11.43 ± 9.00) were significantly
different (P < 0.05) and it was lower than those for unvac-
cinated control chickens (100.00 ± 0.00) (P < 0.05). The
dead chickens in groups 2 and 3 were found to have ND
lesions but not as many as those found in unvaccinated
control group 1. The disease resistant percentage of chick-
ens in groups 1, 2 and 3 was 0.00, 68.57 ± 18.64 and
88.57 ± 9.00, respectively with statistical significance of P
< 0.05. Percentage of morbidity of live birds of groups 2
and 3 at 2 weeks after challenge was 37.89 ± 14.36 and
14.76 ± 12.40, respectively (P < 0.05).
The effect of NDV vaccine on weight gain and FCR
The results of weight gain, feed intake and FCR are shown
in table 1. At 1–28 days old, the weight gain of chickens
in the vaccine groups was not significantly different from
that of the control group. The feed intake between the vac-
cine groups was significantly different (P < 0.05) but it
was not significantly different from that of the control
group. The FCR of the chickens in group 2 revealed the
best among all groups. At 28–42 days old, the weight gain
and feed intake of chickens in the vaccine groups were sig-
nificantly diffferent (P < 0.05). The FCR of group 2 could
not be calculated because it was in the negative value. At
1–42 days old, the body weight gain, feed intake and FCR
of group 3 were significantly better than those of group 2
(P < 0.05).
Discussion
It is well known that a combination of live and inactivated
oil adjuvant Newcastle disease vaccines could elicit the
protection against vvNDV challenge [5]. So, we would like
to compare the disease resistance of chickens against
vvNDV by using different strains of live virus vaccine vac-
cinated at 1 day old. In this experiment it was found that
all chickens in the non-vaccinated group 1 died after chal-
lenge. Chickens in groups 2 (vaccinated with IOAV and B1
strain live vaccine) and 3 (vaccinated with IOAV and
Ulster 2C strain live vaccine) exhibited resistance after
challenge. The chickens in group 3 revealed the protection
from the vvNDV better than the chickens in group 2.
According to Folitse et al [20], the reason for the high anti-
body response obtained with killed-in-oil plus live virus
vaccines given simultaneously could be that initially, the
live virus replicates quickly in the mucosal membrane of
the conjunctiva and the nostrils, eliciting a primary
immune response. This is followed by a continuous slow
release of the killed virus antigen trapped in the oil
medium, thus allowing the killed virus antigen to behave
as a booster dose. Russell [18] and Kohn and Ebert [19] who
showed that Ulster 2C strain can replicate in the Harde-
rian gland and induce IgA in the tears and also it is known
to stimulate immunity in the intestinal loop that can elicit
higher HI titers comparing to Hitchner B1 strain. Accord-
ing to our experiment, once vaccination at one day old
cannot give sufficient immunity to protect chickens until
slaughter at 42 days old. The results reveal that chickens in
group 2 had 68.57 ± 18.64% disease resistance because
the live B1 strain vaccine evoked local immunity in the
respiratory tract [21] which develops 2 days after vaccina-
tion. This response comes from the cell-mediated
response [16]. Zakey-Rones and Levy [22] pointed out that
a local immunity response which has previously been
shown to be evoked by local administration of antigen
might be unaffected by the presence of maternal antibod-
ies. The live Ulster 2C strain virus vaccine, which mainly
multiplies in the intestinal loop such as caecal tonsil and
rectum but it also, multiplies in the epithelial cells of the
respiratory tract [19,23] that triggers higher immune
response. It is accordance with the results of disease resist-
ance and morbidity rate of chickens in group 3 are better
than chickens in groups 2. These results are in agreement
with the work of van Eck et al. [14] who showed that chick-
ens immunized with Ulter 2C strain vaccine give a better
response than chickens vaccinated with B1 strain when
Table 1: Body weight gain, feed intake and FCR of chickens at 1–28, 28–42 and 1–42 days old (Mean ± SD)














1 (n = 6) 9.62 ± 0.78a 15.12 ± 0.41a,b 1.55 ± 0.11a -# --- --
2 (n = 7) 10.08 ± 0.57a 14.73 ± 0.74a 1.46 ± 0.03b 0.67 ± 2.73a 12.28 ± 1.12a# #10.75 ± 1.44a 27.02 ± 1.68a 2.51 ± 0.09a
3 (n = 7) 10.25 ± 0.49a 15.54 ± 0.38b 1.52 ± 0.07a,b 3.20 ± 1.71b 14.11 ± 1.06b 5.59 ± 2.88 14.68 ± 1.00b 29.65 ± 1.26b 2.02 ± 0.06b
#All chickens died.
##The values cannot be calculated because of minus value
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exposed to the vaccines at 1–10 days of age. Another rea-
son for the differences in the response could be related to
the secondary (anamnestic or recall) response which indi-
cates potential virulence of the virus strain used in the
challege. Chickens in group 3, received Ulster 2C, had
lower the morbidity and mortality than chickens in group
2. Under the conditions of the experiment reported here,
it has been shown that simultaneous vaccination with B1
and IOAV, and Ulster 2 C and IOAV of 1-day-old chicks
with maternally derived antibodies gave some protection
of 28-day-old broilers without a booster vaccination. Live
birds of group 2 depicted higher morbidity rate than birds
of group 3. Thus the carcass quality of chickens vaccinated
with B1 strain was lower than that of birds exposed to
Ulster 2C strain.
Chickens in group 2 at 1–28 days old (before challenge)
had the best FCR. They were followed by chickens in
groups 3 and 1. This is in agreement with van Eck and
Goren [13] who showed that Ulster 2C vaccine retards
growth of chickens that have high maternal immunity. At
28–42 days old (after challenge), the body weight gain
and feed intake chickens in group 3 had statistically signif-
icant difference (P < 0.05) of better than chickens in group
2 because the mortality rate of chickens in group 2 was
higher than that of chickens in group 3. Anyhow, during
1–42 days old, the body weight gain, feed intake and FCR
of group 3 were significantly better than those of chickens
in group 2 (P < 0.05).
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